Cancer’s deadliest talent is not rapid growth but the ability to sidestep the internal programs that should make damaged ...

Experts at SICP 2025 outline how molecular mechanisms and bedside assessments can guide personalised treatment for ...

A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, ...

Researchers have identified a stress-activated control mechanism that helps breast cancer cells reshape gene activity to ...

The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny ...

ER+/PR+ breast cancer is a subtype of ER positive breast cancer where the tumor cells express both estrogen receptors (ER) and progesterone receptors (PR) on the surface. As the most common type of ...

Molecular glues are revolutionizing cancer therapy by targeting undruggable proteins for degradation, enhancing precision ...

Read more about New AI Framework ‘OncoMark’ Decodes Cancer’s Molecular Signatures with Precision on Devdiscourse ...

A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease This retrospective analysis ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators from Baylor College of Medicine, ...